Fidelity Investments
ENZN

Fidelity Investments’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Fidelity Investments’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-797,311
Closed -$821K – 2848
2014
Q1 		$821K Sell
797,311
-117,054
-13% -$121K ﹤0.01% 2496
2013
Q4 		$1.06M Buy
914,365
+200,401
+28% +$309K ﹤0.01% 2443
2013
Q3 		$1.2M Buy
713,964
+52,635
+8% +$97.4K ﹤0.01% 2424
2013
Q2 		$1.32M Buy
+661,329
New +$1.94M ﹤0.01% 2373

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments's ENZN Position: Q2 2014 in Review

Fidelity Investments sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2014, closing a stake of 797,311 shares — an estimated $821K sold.

Fidelity Investments first reported a position in ENZN in Q2 2013 and held it in 4 quarters. The position peaked at $1.32M in Q2 2013. 67 funds tracked by Wall St. Rank hold ENZN as of Q2 2014.

  • Fidelity Investments reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2014 after selling out during the quarter.
  • Fidelity Investments sold 797,311 ENZON PHARMACEUTICALS INC shares in Q2 2014, an estimated $821K.
  • Fidelity Investments first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 4 quarters.
  • Fidelity Investments's ENZON PHARMACEUTICALS INC position peaked at $1.32M in Q2 2013.
  • 67 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2014.

Based on Fidelity Investments's 13F filing for Q2 2014, filed 14 Aug 2014.